Overview
- The Secretariat for Anti-Corruption and Good Governance began administrative proceedings on October 1 that could lead to fines and disqualifications for companies that did not fulfill medicine delivery contracts.
- The action follows a September 23 list from Health Subsecretary Eduardo Clark naming roughly 30–34 noncompliant providers, including PiSA, Productos Farmacéuticos Serral, Accord Farma, Bioxintegral and Comercializadora UCIN.
- President Claudia Sheinbaum said verified government debts to suppliers will be paid, but she stressed that arrears do not excuse failure to deliver under contract and warned that proven malice could trigger criminal complaints.
- Industry group Canifarma contests the narrative, citing official supply levels of 93–97%, pointing to about 14 billion pesos in unpaid bills, and noting that many named entities are distributors rather than manufacturers.
- Officials report higher receipts in recent months, yet hospitals continue to report gaps in availability, with oncology medicines highlighted as a persistent vulnerability.